Latest PEG ratio for Zhejiang Starry Pharmaceutical ,Ltd.: 643.53 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow643.53
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Zhejiang Starry Pharmaceutical ,Ltd. (603520.SS) currently reports a PEG ratio of 643.53. That is above the sector sector average of 10.01. Use the charts on this page to explore Zhejiang Starry Pharmaceutical ,Ltd.'s PEG ratio history and peer comparisons.
Zhejiang Starry Pharmaceutical ,Ltd.'s PEG ratio of 643.53 is higher than the its sector sector average of 10.01. That is roughly 6327.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Zhejiang Starry Pharmaceutical ,Ltd.'s market price to a fundamental measure such as earnings, sales, or book value. At 643.53, 603520.SS can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of 643.53, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 10.01. From there, open related valuation or income-statement pages for Zhejiang Starry Pharmaceutical ,Ltd., and consider following 603520.SS for alerts when major investors trade the stock.